Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gary Ishkanian"'
Autor:
Boris Chulpayev, Doreen E Aboagye, Lin Liu, Gary Ishkanian, Dariush Alaie, Jing Miao, Bangaruraju Kolanuvada, Richard L. Petrillo
Publikováno v:
The American Journal of Case Reports
Patient: Female, 58 Final Diagnosis: NMO Symptoms: New-onset right leg weakness and pain Medication: — Clinical Procedure: Progressive and recurring Specialty: Neurology Objective: Rare disease Background: Neuromyelitis optica (NMO) is a rare demye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46dac1ef3526af6e6d66a82d011b83fe
https://doi.org/10.12659/ajcr.906150
https://doi.org/10.12659/ajcr.906150
Publikováno v:
Drug Development Research. 68:441-448
Acute migraine is a major public health problem with a significant economic burden secondary to short-term disability and absenteeism. Treatment of acute migraine is always challenging for primary care physicians and family practitioners, as there ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f9e3226bbd6e094827d0791d11ffd45
https://doi.org/10.1002/ddr.20213
https://doi.org/10.1002/ddr.20213
Autor:
Christopher J. Webster, Harvey J. Blumenthal, Mary S. Richardson, Michael Ames, Gary Ishkanian
Publikováno v:
Clinical Therapeutics. 29:99-109
Many patients and physicians interpret episodic headache in the presence or absence of nasal symptoms as "sinus' headache, while ignoring the possible diagnosis of migraine.The purpose of this study was to assess the efficacy and tolerability of suma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28f302ec1bab7662f00846adea4c0f4
https://doi.org/10.1016/j.clinthera.2007.01.012
https://doi.org/10.1016/j.clinthera.2007.01.012
Autor:
George H. Sands, David Kudrow, Gary E. Ruoff, Vu H. Le, Gary Ishkanian, H. Mikel Thomas, Mark T. Brown
Publikováno v:
Headache: The Journal of Head and Face Pain. 45:1151-1162
Objective.—To evaluate the analgesic efficacy and safety of a single 20- or 40-mg dose of valdecoxib compared with placebo in treatment of a single, acute, moderate or severe migraine headache, with or without aura. Background.—Valdecoxib, an ora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c7cd9845a32121bf59cbfb10541818
https://doi.org/10.1111/j.1526-4610.2005.00238.x
https://doi.org/10.1111/j.1526-4610.2005.00238.x
Publikováno v:
The Journal of Clinical Pharmacology. 44:1158-1165
Frovatriptan is a selective 5-HT(1B/1D) receptor agonist available for acute treatment of migraine in adults (18 years and older). The objective of this study was to determine key pharmacokinetic parameters of frovatriptan in adolescent migraineurs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d900d6b36f7adb936808688a8b98f8
https://doi.org/10.1177/0091270004268046
https://doi.org/10.1177/0091270004268046
Autor:
Ninan T. Mathew, Steven L. Linder, Gary Finlayson, Donald W. Lewis, Roger Cady, Gary Ishkanian
Publikováno v:
Headache. 48(9)
To assess the efficacy and safety of almotriptan 6.25 mg, 12.5 mg, and 25 mg vs placebo for acute migraine treatment in adolescents.In this double-blind, placebo-controlled, parallel-group, multicenter trial, 866 patients aged 12 to 17 years with a1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82bb4a1ad3b2d83af7743d602fed029
https://pubmed.ncbi.nlm.nih.gov/18484981
https://pubmed.ncbi.nlm.nih.gov/18484981